B-Galactosidase activities were determined in fibroblast preparations derived from the bone marrow and skin of a patient with G M~ gangliosidosis and from 11 control subjects. Two B-galactosidase substrates were employed in these studies: ganglioside GMI, labeled with tritium in the terminal galactose by a new procedure, and o-nitrophenyl-P-galactopyranoside. The GMI-B-galactosidase activity in the cells of the patient was reduced 17-to 30-fold compared with the activity in the cells of the control subjects; also, the cells of the patient exhibited a n 11-to 30-fold depression in o-nitrophenyl-B-galactosidase activity (ONP-B-galactosidase). These results demonstrated that fibroblasts cultured from a n affected subject might be employed for diagnostic purposes. The GMI-and o-nitrophenyl-B-galactosidase activities of fibroblasts cultured from normal amniotic fluid have also been determined; o-nitrophenyl-B-galactosidase activities ranged from 61 to 153 units/106 cells and the GM I-8-galactosidase activities varied between 45 and 95 units/ 1 O8 cells.
Introduction
[(2 + 3)-N-acetylneuraminyll-galactosyl-(1 + 4)-glucosyl-( 1 + 1)-[2-N-acyll-sphingosine, in the brain Generalized gangliosidosis (GMl gangliosidosis) is a and visceral organs [9, 11, 221 . Clinically, the disorder rare inherited metabolic disorder characterized by the is manifested by progressive neurological deterioration, accumulation of large quantities of GMl ganglioside, accumulation of glycolipid in neurons and reticulogalactosyl-(1 + 3)-N-acetyl-galactosaminyl-(I + 4)-endothelial cells, skeletal and facial features similar to those seen in Hurler's syndrome, and death by 2 years of age. DERRY et al. [3] have proposed that there is a second form of GMl gangliosidosis in which ganglioside GM1 (GMl) accumulates only in the brain without osseous defects or visceromegaly.
A deficiency of o-and p-nitrophenyl-j3-galactosidase activity has recently been demonstrated in the liver, spleen, kidney, and brain of four patients with GMl gangliosidosis [2, 12, 151 . In addition, OKADA and O'BRIEN [I21 demonstrated depressed levels of G M~-j3-galactosidase activity in tissues from two of these patients. Deficiency in the activity of lysosomal 8- galactosidase, which normally cleaves the terminal galactose from the oligosaccharide moiety of GM1, probably accounts for the accumulation of GMl in generalized gangliosidosis.
We have determined the j3-galactosidase activity with o-nitrophenyl-j3-D-galactopyranoside (ONPG) as substrate in fibroblast cultures derived from the skin and from bone marrow of a patient with GMl gangliosidosis and in cultures from 11 control subjects. An additional method using tritiated GMl (GM1m3H) was also developed to assay the enzyme.
Subjects and Methods
Patient MB (NIH 07-22-86) was 14 months old at the time the biopsies for initiation of cell cultures were obtained; he died at the age of 2 years. The diagnosis of GMl gangliosidosis was established by isolating and quantifying the gangliosides from portions of brain and liver 110, 221. These tissues contained 1,900 and 108 pg of G M~ sialic acid/g wet weight, respectively, an increase of 20-50 times the normal GM1 content [3, 19, 201. Control cells were derived from one normal subject and from patients with diseases other than GM1 gangliosidosis. The control subjects ranged in age from 6 months to 26 years of age. Cultures were initiated from bone marrow aspirates and from 3-mm punch skin biopsies [23] . The growth medium used was Eagle's 'minimum essential medium' containing the nonessential amino acids [5] , 10 % fetal bovine serum and neomycin (50 pg/ml). Usually in 3 weeks sufficient outgrowth of fibroblasts from primary explants occurred to permit subcultivation of the cells at 3-to 6-day intervals. The cells used for subcultivation were removed from the glass surface and dispersed with 0.25 % trypsin. As viewed under the light microscope, the cell morphology and growth pattern of the cells from the patient with G M~ and those from the control subjects were the same.
Cells used for enzyme assays were grown as monolayer cultures in 32-02 prescription bottles. At the time of' harvesting the cells were rinsed with Ca2+, Mg2+-free Dulbecco's saline solution [4] and removed from the glass by treatment with this solution containing: (in percent) trypsin, 0.05; ethylenediaminetetraacetate (EDTA), 0.005; and methylcellulose, 0.2. Cells, x 106, were then suspended in 40 ml of Dulbecco's saline containing 0.1 % methylcellulose, and a 0.5-ml aliquot was removed for counting [28] . The cell suspension was then centrifuged at 600 x g; the pellet was resuspended in 10 ml of cold methylcellulose-saline and centrifuged at 600 xg. The cell pellet was stored at -80' until processed further.
Other cells were suspended in 1 ml of 0.25 M sucrose containing 2.5% Cutscum (isooctylphenoxypolyoxyethanol) [29] and disrupted by the microtip of a sonifier [30] . The output control selector was set at no.2 and the output of the microtip was 1.2 amp. The cells were sonified at 0' for two 30-sec periods, interrupted by a 1-min pause. Aliquots of the resulting preparation were assayed immediately or after storage at -70'. Repeated freezing and thawing did not affect the activity of the various enzymes assayed.
The incubation mixture for the assay of ONP-j3-galactosidase activity contained an aliquot of the fibroblast preparation representing approximately lo5 cells; 25 pmoles of sodium acetate buffer, pH 5.1; 1.33 pmoles of ONPG; 200 pg of Cutscum; and water in a final volume of 0.2 ml. After incubation for 90 min at 37O, the reaction was terminated by the addition of 0.1 ml of human serum albumin (100 mg/ml) and 0.5 ml of 4% trichloroacetic acid. The clear supernatant solution obtained by low speed centrifugation (500 x g) was pipetted into 0.4 ml of 1 M sodium carbonate. The o-nitrophenol concentration was determined by measuring the optical density at 415 mp. One unit of ~~~-/ ? -~a l a c t o s i d a s e activity was defined as the amount of enzyme required to catalyze the hydrolysis of 1 nmole (nanomole) of ONPG/h under the standard conditions. GMI, isolated from the brain of patient MB, was tritiated by oxidation with galactose oxidase followed by reduction with sodium borohydride-3H (17) . The radioactive GMl was purified by column chromatography on Anasil S [I 31. The purified G M I -~H migrated as a single band on thin-layer plates of silica gel G that were developed in either chloroform-methanol-2.5 N ammonium hydroxide (60 : 35 : 8) or n-propanolwater (7:3) [27] . The labeled ganglioside had the same RF as authentic GMl. Incubation of the GM1-3H with rat brain j3-galactosidase [7] demonstrated that more than 90% of the tritium was in the terminal galactose moiety.
GMvrl-" was used as a specific substrate for the determination of GM1-8-galactosidase activity. The incubation mixture contained an aliquot of the fibroblast After incubation for 90 min at 37O, the reaction was terminated by heating for 3 min at 100'. The galactose liberated f r o m G~1 was separated from excess GMl and the other reaction product, ganglioside GMl [31], by thin-layer chromatography. Chromatography was performed on thin-layer plates of silica gel G with chloroform-methanol-2.5 N ammonium hydroxide (60: 35 : 8) as solvent. The area corresponding to galactose was scraped and counted in a liquid scintillation counter with a Triton-toluene counting fluid [I] . One unit of GM1-p-galactosidase activity was defined as the amount required to catalyze the release of 1 nmole galactose-3H/h under the standard conditions. The galactosidase activity as measured with ONPG or GMVr1-3H was linear with respect to time and enzyme concentration over the range examined.
Acid phosphatase and B-N-acetyl-galactosaminidase activities of the tissue culture preparations were also determined [8, 181 . The substrates, p-nitrophenylphosphate and p-nitrophenyl-j3-N-acetylgalactosaminide, were obtained commercially [32] .
Results and Discussion
A deficiency of both ONP-j3-galactosidase and ganglioside GM1-/3-galactosidase activities was found in fibroblast cultures derived from skin and from bone marrow biopsies of patient MB (table I). The ONP-Pgalactosidase activity in his cultures was 2.5-10% of the activity in the cultures from control subjects. With GMl-3H /3-Galactosidase in tissue cultures from h u m a n skin a n d bone marrow as substrate, cell cultures of patient MB demonstrated no activity by an assay capable of detecting 3 units of activity per lo8 cells; GM1-B-galactosidase activity was less than 6% of that in the least active control culture. The deficiency of activity against either galactoside was specific for GM1 gangliosidosis (table I).
The activities of two other lysosomal hydrolases, acid phosphatase and j3-N-acetylgalactosaminidase, were determined to demonstrate the metabolic competency of the cells from patient MB. The activities of these enzymes were not depressed (table I) . Aliquots of a single sonically disrupted cell preparation were used for multiple /3-galactosidase and 'control' enzyme assays. In most cases the values in table I are the means of values from two or three assays. In three subcultures of skin and two of the bone marrow, cells of patient MB exhibited low levels of ONP-and GM1-8-galactosidase activity.
The results of assays for ONP-and GMl-/3-galact0si-dase activities in control cells with and without admixture of cells from the patient are shown in table 11. Cells from the patient did not inhibit ONP-j3-galactosidase activity; however, there appeared to be a decrease in the GM1-j3-galactosidase activity of the control cells in the presence of cells from patient MB. This depressed activity was eliminated by tripling the concentration of GMl-3H in the incubation mixtures. These experiments indicate that the lower j3-galactosidase activities in the mixtures probably resulted from dilution of the labeled substrate by endogenous G M~ and not from the presence of an inhibitor in the patient's cells. The marked difference between the ONP-and GMl-8-galactosidase activities in the cells of the control subjects was probably the result of the different solubility characteristics of the two substiates. ONPG is water soluble and, therefore, probably more available to the enzyme than GM1, which presumably was present in micellar form. Further metabolism of the galactose liberated from GM1 would also result in a lower apparent GMl-B-galactosidase activity. The latter possibility is probably of minor importance, however, since more than 90% of the GM1 could be recovered following incubation.
We have also cultured a number of cell lines from the fetal cells present in amniotic fluids, obtained by transabdominal amniocentesis or at therapeutic abortion after 12-20 weeks of gestation. ONP-j3-galactosidase and GMl-/I-galactosidase activities were assayed in four of these lines. The ONP-/3-galactosidase activities ranged from 61 to 153 units/106 cells; the G~i-j3-galactosidase activities varied between 45 and 95 units/108 cells [24] . Thus, cultures derived from amniotic fluid may make possible the detection of G M~ gangliosidosis in the developing fetus as early as week 22 of gestation.
Sodium borohydride-3H, with a specific radioactivity of 400 mCi/mmole, was used in the preparation of the GMl-3H, and yielded a labeled substrate that permitted the determination of the GMl-j3-galactosidase activity in lo5 fibroblasts. Sodium borohydride-3H is now available with a specific radioactivity of 6 Ci/mmole.
If this reagent was employed, a 15-fold increase in the specific radioactivity of GMl-3H could be obtained. Use of this substrate and prolonged incubation of the assay might permit the determination of the GM1-bgalactosidase activity in cultured cells as early as 2 weeks after the amniotic fluid was obtained.
After this work was completed, PINSKY et al. [14] reported depressed levels of ONP-/?-galactosidase activity in cultured fibroblasts of a patient in which GM1 accumulated only in the brain.
'Generalized' and 'cerebral' GMl gangliosidosis may represent two manifestations of homozygosity for the same defective gene. The amounts of visceral mucopolysaccharides and visceral glycolipids are two differences in the chemical pathology of these two forms of the disorder [2 11. I t seems possible that these two forms of GMl gangliosidosis may actually result from two different mutations at the p-galactosidase locus.
Compared with the normal enzyme, the mutant enzymes might possess different relative affinities for GMl and mucopolysaccharides. Alternatively, one mutation might lead to a more severe deficiency of enzymatic activity and, therefore, to a more generalized accumulation of GM1. The ready accessibility of this enzymatic activity in cultured fibroblasts may assist in the further assessment of these two possibilities. I t is also entirely possible that enzymatic analysis of cultured fibroblasts may permit detection of the heterozygous state in GM1 gangliosidosis.
